Generalized Anxiety Disorder 2-item (GAD-2)
Assessment tool
A total does not establish individual item responses.
Over the last 2 weeks, how often have you been bothered by the following problems?
Responses stay in this page’s memory. Reset or leave the page to clear them. No patient identifiers are collected.
About this scale and references
Reference information · Questionnaire
- Last content update
- 2026-10-26
- Clinical review
- Not independently reviewed
- Source jurisdiction
- See individual sources
- Coverage
- Questionnaire
| Field | Instrument context |
|---|---|
| Version | Standard adult English; University of Washington source wording |
| Population | Adults |
| Respondent | Self-report |
| Recall period | Past 2 weeks |
| Purpose | Symptom screening and measurement; requires clinical interpretation |
Interpretation & limitations
- Higher scores reflect greater reported symptom burden; results do not establish a diagnosis.
- Use clinical judgment, functional impact, history and clinical interview alongside the score.
- All scored items must be answered; missing responses are not zero and no total is produced for an incomplete form.
- The cutoff of 3 is a screening threshold, not a symptom-severity band. A positive screen warrants further clinical evaluation; consider the full GAD-7.
- A low score does not rule out a mental health condition or establish safety.
- This is the adult English version; an independently validated translation is not supplied.
- No automatic diagnosis, medication change or declaration of safety may be generated.
References · 2
- University of Washington National HIV Curriculum: Generalized Anxiety Disorder 2-item (GAD-2)
- Pfizer: free public access to PHQ and GAD assessment tools · Pfizer released PHQ and GAD questionnaires without copyright restriction and at no charge. Preserve developer attribution; Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke and colleagues, with an educational grant from Pfizer Inc.